We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Exosome-based mixture remedy reveals promise for therapy of metabolically difficult illness MASH
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Exosome-based mixture remedy reveals promise for therapy of metabolically difficult illness MASH
Exosome-based mixture remedy reveals promise for therapy of metabolically difficult illness MASH
Health

Exosome-based mixture remedy reveals promise for therapy of metabolically difficult illness MASH

Last updated: April 25, 2025 3:55 am
Editorial Board Published April 25, 2025
Share
SHARE

Graphical summary. Credit score: Biomaterials (2025). DOI: 10.1016/j.biomaterials.2025.123321

DGIST Division of New Biology Professor Yea Kyungmoo and his analysis crew have developed a next-generation exosome-based drug-delivery know-how to successfully deal with metabolic dysfunction-associated steatohepatitis (MASH), an incurable metabolic illness, in collaboration with Professor Baek Moon-chang of Kyungpook Nationwide College College of Drugs.

The paper is printed within the journal Biomaterials.

MASH is a fancy illness that accompanies varied metabolic illnesses, comparable to weight problems and diabetes, and present therapies are restricted of their effectiveness since they aim solely a single pathological mechanism. Some candidates have both failed scientific trials or are delayed in approval attributable to cardiovascular unintended effects or long-term use issues. Such circumstances reveal the necessity for safer and more practical mixture therapy methods.

To handle these challenges, Professor Yea’s analysis crew achieved the simultaneous engineering of the inside and the floor of extracellular vesicles (exosomes), biologically derived particles that play an important position in delivering indicators between cells, to formulate a bifunctional drug-delivery system that’s particular to the therapy of pathologically complicated MASH.

Exosomes, which carry varied molecules together with proteins, lipids, and genetic supplies, are produced naturally within the physique and are thought of a promising next-generation drug-delivery system as a result of they’ve larger biocompatibility, decrease toxicity, and fewer unintended effects than present lipid-based drug-delivery methods (comparable to COVID-19 vaccines).

The analysis is designed to manage metabolic abnormalities, irritation, and fibrosis concurrently, the primary pathological mechanisms of MASH, by attaching the potent fat-burning protein Fibroblast Development Issue 21 (FGF21) to the floor of the exosomes, and enclosing miRNA-223, which is efficient for regulating irritation and fibrosis. Particularly, the exosomes could also be delivered explicitly to liver tissues, maximizing therapy effectivity.

“This research is the first to demonstrate a novel combination treatment concept utilizing exosomes for MASH, a metabolic disease that is difficult to treat. It sheds light on the potential to overcome the limitations of existing treatment strategies,” Professor Yea mentioned. “We hope to establish a mass production system in the future that will lead to actual drug development.”

Extra info:
Hanchae Cho et al, Engineered extracellular vesicles with floor FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitis, Biomaterials (2025). DOI: 10.1016/j.biomaterials.2025.123321

Offered by
Daegu Gyeongbuk Institute of Science and Know-how

Quotation:
Exosome-based mixture remedy reveals promise for therapy of metabolically difficult illness MASH (2025, April 24)
retrieved 24 April 2025
from https://medicalxpress.com/information/2025-04-exosome-based-combination-therapy-treatment.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Research finds key gene loss could set off untimely getting old within the mind

Weight problems prevalence would shift considerably underneath proposed new standards, research finds

Steady glucose screens are in vogue. However do you really want to trace your blood sugar?

What’s chikungunya virus, and may we be apprehensive about it in Australia?

Texts about more healthy consuming might assist forestall childhood weight problems

TAGGED:challengingcombinationdiseaseExosomebasedmashmetabolicallypromiseshowstherapytreatment
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Richard Fierro: The Army Veteran Who Disarmed the Club Q Gunman

Richard Fierro: The Army Veteran Who Disarmed the Club Q Gunman

Editorial Board November 23, 2022
Rocker Marilyn Manson drops lawsuit towards Evan Rachel Wooden, can pay authorized charges
Pippa Garner, Ingenious Conceptual Tinkerer, Dies at 82
Nets outlast Pacers 99-90 to snap three-game skid
Consultants forecast an ongoing melancholy and value of care burden by means of 2032 in Hong Kong

You Might Also Like

New analysis uncovers gene impacts of PFAS publicity in firefighters
Health

New analysis uncovers gene impacts of PFAS publicity in firefighters

July 26, 2025
Injured as soon as, triggered ceaselessly? How the mind rewrites stress responses
Health

Injured as soon as, triggered ceaselessly? How the mind rewrites stress responses

July 26, 2025
Microscopy reveals how Hippo pathway proteins management gene exercise in most cancers
Health

Microscopy reveals how Hippo pathway proteins management gene exercise in most cancers

July 26, 2025
Mind peptide ODN reduces starvation and boosts glucose regulation in rat research
Health

Mind peptide ODN reduces starvation and boosts glucose regulation in rat research

July 26, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?